Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,523 across all filing types
Latest filing 2021-02-01 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
PROPOSED ISSUE OF RMB SHARES UNDER SPECIFIC MANDATE PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION
Capital/Financing Update Classification · 95% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding a proposed domestic issue of RMB shares under a specific mandate, including details about the share issuance, pricing, target subscribers, use of proceeds, and authorization for the board to handle related matters. It references an upcoming Extraordinary General Meeting (EGM) for shareholder approval and discusses regulatory approvals and procedural steps. The content is focused on capital raising activities and share issuance, not on financial results, management changes, or legal proceedings. The document is lengthy (15,000 characters) and contains detailed information about the capital raising plan, which aligns with a Capital/Financing Update. It is not a report publication announcement or a regulatory filing since it contains substantive details about the financing proposal itself. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-02-01 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including committee memberships. It does not contain financial data, audit results, or detailed management discussion. It is an announcement related to the company's board structure and membership. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, confirming it is not a full report or announcement of voting results.
2021-01-27 English
APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF BOARD COMMITTEE S
Board/Management Information Classification · 100% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding the appointment and resignation of independent non-executive directors and changes in board committees. It details the biographical information of the new appointees, their service agreements, and compliance with listing rules. There is no financial data, earnings information, or report publication mentioned. The content focuses solely on board and management changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed information about management changes, confirming the classification with high confidence.
2021-01-27 English
VOLUNTARY ANNOUNCEMENT - NBL-012 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CSPC Pharmaceutical Group Limited regarding the approval of a clinical trial application (IND) by the U.S. FDA for a drug candidate NBL-012. It is a short announcement (3421 characters) focused on a specific event related to clinical trial approval. There are no financial statements, no detailed financial performance data, no regulatory certifications, no voting results, no management or board changes, no earnings or capital updates, and no mention of any report being attached or published. The content is an announcement of a milestone event rather than a report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-01-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, including share options, warrants, convertibles, and other share-related transactions. It includes confirmations by a director regarding compliance with listing rules and legal requirements. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements to the stock exchange, not a full financial report or announcement of voting results. Therefore, it fits best under 'Regulatory Filings' (RNS) as a general regulatory announcement about share capital movements.
2021-01-04 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including details about board committees and their memberships. It does not contain financial data, audit results, or any report content. It is an announcement related to the company's board structure and management information. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, confirming this classification.
2020-12-31 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.